Early intravenous gamma-globulin treatment for Kawasaki disease: the nationwide surveys in Japan.
暂无分享,去创建一个
J. Furui | T. Matsuishi | M. Ishii | H. Yanagawa | H. Muta | T. Akagi | K. Egami | Y. Sugahara | Yoshikazu Nakamura
[1] B. McCrindle,et al. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease. , 2002 .
[2] H. Yanagawa,et al. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. , 2001, Pediatrics.
[3] B. McCrindle,et al. Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease. , 2000, Archives of pediatrics & adolescent medicine.
[4] S. Colan,et al. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. , 1998, The Journal of pediatrics.
[5] M. Freed,et al. Special Report Diagnosis and Therapy of Kawasaki Disease in Children , 1993, Circulation.
[6] K. Harada. Intravenous γ‐Globulin Treatment in Kawasaki Disease , 1991 .
[7] N. Sreeram,et al. Sudden death in incomplete Kawasaki disease. , 1989, Archives of disease in childhood.
[8] S. Gidding,et al. Incomplete Kawasaki disease with coronary artery involvement. , 1987, The Journal of pediatrics.
[9] J. Furui,et al. The Effectiveness and Safety of Early Intravenous Immune Globulin Treatment for Kawasaki Disease , 2003, Pediatric Research.
[10] H. Yanagawa,et al. Use of Intravenous γ-Globulin for Kawasaki Disease: Effects on Cardiac Sequelae , 1997, Pediatric Cardiology.